Insiders · NRXP

Michael S Abrams

Chief Financial Officer at NRX Pharmaceuticals, Inc. (NRXP) since November 2024

Michael S Abrams has filed 3 insider reports with the SEC since November 2024, as chief Financial Officer at NRX Pharmaceuticals, Inc. (NRXP). The latest filing, on November 4, 2026, reports grant or award at NRX Pharmaceuticals, Inc. (NRXP).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael S Abrams is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
NRX Pharmaceuticals, Inc. logo
NRXP
NRX Pharmaceuticals, Inc.
Chief Financial Officersince November 2024$2.55Nov 4, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Michael S Abrams with

Other insiders at the same companies

Questions about Michael S Abrams

What is Michael S Abrams's role at NRX Pharmaceuticals, Inc.?
Michael S Abrams reports to the SEC as chief Financial Officer at NRX Pharmaceuticals, Inc. (NRXP), according to the latest filing on November 4, 2026.
Has Michael S Abrams bought or sold stock recently?
No open-market purchases or sales by Michael S Abrams are on file. The filings report grant or award.
How do I get alerts when Michael S Abrams files?
Follow Michael S Abrams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael S Abrams filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Michael S Abrams (SEC CIK 0001497702). Totals count each trade once, skipping amendments whose original is on file, from Nov 22, 2024 on. View on SEC EDGAR · Get this as JSON